Biotechnology Industry Organization (BIO) White Paper Addresses the Challenges of Creating Any Pathway for Follow-On Biologics
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) released today a white paper entitled, “The Difference with Biologics: The Scientific, Legal and Regulatory Challenges of Any Follow-On Biologics Scheme.”